clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Men with Cardiovascular Disease Risk Show Brain Health Decline a Decade…
Molecular Dx
Early Research Suggests Congenital Heart Defects Linked to Placenta
News & Features
GLP-1 Obesity Drugs Also Provide Substantial Kidney Protection
News & Features
Scribe Therapeutics Verifies In Vivo CRISPR-Based Cardiometabolic Therapies
Molecular Dx
Genetics of Type 2 Diabetes in South Asians Explored
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
The SHIELD: La Jolla Institute for Immunology Gets $49M to Drug Herpesviruses
Human cytomegalovirus
News & Features
The SHIELD: La Jolla Institute for Immunology Gets $49M to Drug Herpesviruses
Jonathan D. Grinstein, PhD
September 26, 2024
0
News & Features
T Cell Discovery Unlocks Potential for Crafting Tailored Immune Responses
October 26, 2023
0
Molecular Dx
Epigenetic Inhibitors Could Help Target Human Cytomegalovirus
February 23, 2021
0
News & Features
Clinical OMICs Magazine Volume 1, Issue No. 8
August 13, 2014
0
Related Content
Lipoprotein(a) Lowering Draw Between Lilly and Silence
Long COVID Linked to Persistent Infection
UCLA Receives $120 Million Gift to Establish the California Institute for Immunology and Immunotherapy
COVID-19 Nasal Vaccine Ready for Clinical Trials
Inside Precision Medicine
